Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-15 Sale | 2026-04-17 4:53 pm | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 218,600 | $4.0349 | $882,028 | 295,224 (Direct) | View |
| 2026-04-13 Sale | 2026-04-15 7:59 pm | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 118,849 | $3.6 | $427,860 | 397,106 (Direct) | View |
| 2026-04-09 Sale | 2026-04-13 8:34 pm | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 56,596 | $3.5537 | $201,124 | 515,955 (Direct) | View |
| 2026-04-09 Sale | 2026-04-10 6:46 pm | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 14,500 | $3.38 | $49,010 | 518,622 (Direct) | View |
| 2026-04-06 Sale | 2026-04-08 8:32 pm | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 260,427 | $3.4541 | $899,538 | 533,122 (Direct) | View |
| 2026-04-02 Sale | 2026-04-03 6:17 pm | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 26,858 | $3.48 | $93,466 | 1,624,697 (Direct) | View |
| 2026-03-02 Sale | 2026-03-10 7:36 pm | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 5,100 | $3.3096 | $16,879 | 77,079 (Direct) | View |
| 2026-03-02 Sale | 2026-03-10 7:36 pm | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 2,594 | $3.3096 | $8,585 | 41,600 (Direct) | View |
| 2026-03-02 Sale | 2026-03-10 7:35 pm | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 1,834 | $3.3096 | $6,070 | 216,019 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 6:09 pm | Aadi Bioscience Inc. | AADI | BALL BRYAN See remarks | 2,147 | $2.35 | $5,045 | 217,853 (Direct) | View |
| 2025-03-03 Sale | 2025-03-03 8:38 pm | Aadi Bioscience Inc. | AADI | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 2,806 | $2.35 | $6,594 | 44,194 (Direct) | View |
| 2025-03-03 Sale | 2025-03-03 8:37 pm | Aadi Bioscience Inc. | AADI | Lennon David James CHIEF EXECUTIVE OFFICER | 5,690 | $2.35 | $13,372 | 82,179 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-14 Option Award | 2026-05-18 4:06 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Dugan Margaret Chief Medical Officer | 19,132 | $3.92 | 19,132 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 4:05 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 51,020 | $3.92 | 448,126 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 4:04 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 38,265 | $3.92 | 333,489 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 4:03 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 51,021 | $3.92 | 569,643 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 4:02 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Castelein Caley Director | 255,102 | $3.92 | 4,513,550 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 4:02 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Castelein Caley Director | 2,072,756 | $8,124,996 | 4,513,550 (Indirect) | View |
| 2026-05-12 Option Award | 2026-05-14 7:40 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Avoro Capital Advisors LLC Aghazadeh Behzad Avoro Ventures LLC See Remarks 10% Owner | 6,377,714 | $3.9199 | 14,710,714 (Indirect) | View |
| 2026-04-01 Option Award | 2026-04-03 6:22 pm | N/A 2036-04-01 | Whitehawk Therapeutics Inc. | WHWK | Dornan David Chief Scientific Officer | 282,340 | $0 | 282,340 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 6:21 pm | N/A 2036-04-01 | Whitehawk Therapeutics Inc. | WHWK | Dugan Margaret Chief Medical Officer | 283,157 | $0 | 283,157 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 6:20 pm | N/A 2036-04-01 | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 250,058 | $0 | 822,609 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 6:20 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 366,532 | $0 | 822,609 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 6:18 pm | N/A 2036-04-01 | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 300,677 | $0 | 802,679 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 6:18 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 473,902 | $0 | 802,679 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-03 6:17 pm | N/A 2036-04-01 | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 831,148 | $0 | 1,624,697 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 6:17 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 775,828 | $0 | 1,624,697 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-10 7:36 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 16,250 | $0 | 77,079 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-10 7:36 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 6,750 | $0 | 41,600 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-10 7:35 pm | N/A N/A | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 5,000 | $0 | 216,019 (Direct) | View |
| 2025-12-01 Option Award | 2025-12-02 4:48 pm | N/A 2035-12-01 | Whitehawk Therapeutics Inc. | WHWK | Dugan Margaret Chief Medical Officer | 705,309 | $0 | 705,309 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-17 8:10 pm | N/A 2035-06-17 | Whitehawk Therapeutics Inc. | WHWK | Zhao Baiteng Director | 40,006 | $0 | 40,006 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-17 4:37 pm | N/A 2035-06-12 | Whitehawk Therapeutics Inc. | WHWK | Desai Neil Director | 40,006 | $0 | 40,006 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:58 pm | N/A 2035-06-12 | Whitehawk Therapeutics Inc. | WHWK | Hirmand Mohammad Director | 40,006 | $0 | 40,006 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:56 pm | N/A 2035-06-12 | Whitehawk Therapeutics Inc. | WHWK | Maroun Richard E Director | 40,006 | $0 | 40,006 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:54 pm | N/A 2035-06-12 | Whitehawk Therapeutics Inc. | WHWK | Reeve Emma Director | 40,006 | $0 | 40,006 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:53 pm | N/A 2035-06-12 | Whitehawk Therapeutics Inc. | WHWK | Castelein Caley Director | 40,006 | $0 | 40,006 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:52 pm | N/A 2035-06-12 | Whitehawk Therapeutics Inc. | WHWK | Dalal Anupam Director | 40,006 | $0 | 40,006 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:51 pm | N/A 2035-06-12 | Whitehawk Therapeutics Inc. | WHWK | Aghazadeh Behzad Avoro Capital Advisors LLC Avoro Ventures LLC See remarks 10% Owner | 40,006 | $0 | 40,006 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 7:24 pm | N/A 2035-04-01 | Whitehawk Therapeutics Inc. | WHWK | BALL BRYAN See remarks | 733,064 | $0 | 733,064 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 7:23 pm | N/A 2035-04-01 | Whitehawk Therapeutics Inc. | WHWK | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 947,804 | $0 | 947,804 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 7:22 pm | N/A 2035-04-01 | Whitehawk Therapeutics Inc. | WHWK | Lennon David James CHIEF EXECUTIVE OFFICER | 1,551,656 | $0 | 1,551,656 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-05 7:51 pm | N/A N/A | Aadi Bioscience Inc. | AADI | Dalal Anupam Director | 1,561,000 | $2.4 | 3,411,532 (Indirect) | View |
| 2025-03-04 Option Award | 2025-03-04 7:24 pm | N/A N/A | Aadi Bioscience Inc. | AADI | Castelein Caley Director | 1,666,000 | $2.4 | 2,185,692 (Indirect) | View |
| 2025-03-04 Option Award | 2025-03-04 6:14 pm | N/A N/A | Aadi Bioscience Inc. | AADI | Zhao Baiteng Director | 1,250,000 | $2.4 | 1,250,000 (Indirect) | View |
| 2025-03-04 Option Award | 2025-03-04 6:11 pm | N/A 2035-03-04 | Aadi Bioscience Inc. | AADI | Dornan David Chief Scientific Officer | 687,979 | $0 | 687,979 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 6:09 pm | N/A N/A | Aadi Bioscience Inc. | AADI | BALL BRYAN See remarks | 5,000 | $0 | 217,853 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-04 6:09 pm | N/A N/A | Aadi Bioscience Inc. | AADI | BALL BRYAN See remarks | 100,000 | $2.4 | 217,853 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 5:56 pm | N/A N/A | Aadi Bioscience Inc. | AADI | Aghazadeh Behzad Avoro Capital Advisors LLC Avoro Ventures LLC See Remarks 10% Owner | 8,333,000 | $2.3999 | 8,333,000 (Indirect) | View |
| 2025-03-01 Exercise | 2025-03-03 8:38 pm | N/A N/A | Aadi Bioscience Inc. | AADI | Giacobello Scott M. CHIEF FINANCIAL OFFICER | 6,750 | $0 | 44,194 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-03 8:37 pm | N/A N/A | Aadi Bioscience Inc. | AADI | Lennon David James CHIEF EXECUTIVE OFFICER | 16,250 | $0 | 82,179 (Direct) | View |